Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

CoreAge Rx vs SnagRx

Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, SnagRx a 62. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

CoreAge Rx

#1 · Grade A+ · Best Value

Est. first month

$149/mo

Save ~89% vs brand-name
Get this deal Full CoreAge Rx review →
VS

SnagRx

#352 · Grade C · Watch List

Est. first month

From $299/mo (starting dose, compounded)

Save ~78% vs brand-name
Get this deal Full SnagRx review →

The verdict

Better value: CoreAge Rx

CoreAge Rx takes it on Value Score, 93 to 62 an est. $149/mo first month, with no teaser step-up baked in. SnagRx isn't out of it: Shoppers who want compounded semaglutide and tirzepatide at a flat lifetime price.

CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealCoreAge RxSnagRx
Value Score93 (A+)62 (C)
Est. first month$149/moFrom $299/mo (starting dose, compounded)
Save vs brand-name~89%~78%
Semaglutide$149/moFrom $299/mo (starting dose, compounded)
Tirzepatide$349/moFrom $399/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
52
CoreAge Rx: 88. SnagRx: 52.
98
No Teaser-Rate Bait
64
CoreAge Rx: 98. SnagRx: 64.
98
Nationwide Availability
45
CoreAge Rx: 98. SnagRx: 45.
95
Both Molecules
92
CoreAge Rx: 95. SnagRx: 92.
95
Easy Cancellation
58
CoreAge Rx: 95. SnagRx: 58.
84
Reputation
78
CoreAge Rx: 84. SnagRx: 78.

CoreAge Rx

The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.

Why it's a deal

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation — no lock-in

The fine print

  • Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

SnagRx

SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc.

Why it's a deal

  • Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) on launch discount, flat-priced at every dose
  • Names four partner pharmacies in Terms (RedRock, Health Warehouse, Precision Compounding, Triad Rx)
  • Available in all 50 states plus Washington D.C. per Terms
  • Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
  • Cancel anytime; full refund if disqualified by the medical provider

The fine print

  • Headline $99/$149 prices are discounted from $299/$399 standard; a countdown timer pressures signup
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
  • Refunds only available before medication is ordered; all sales otherwise final
  • Binding JAMS arbitration under Delaware law; class-action waiver
Get the CoreAge Rx deal Get the SnagRx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to SnagRx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.